Aims to provide an above average and increasing income, together with long term capital growth.
Name | % Net Assets |
---|---|
Vodafone Group | 7.6% |
BP | 7.5% |
GlaxoSmithKline | 7.2% |
Royal Dutch Shell | 6.6% |
HSBC Hldgs | 5.8% |
Rio Tinto | 5.2% |
AstraZeneca | 4.5% |
BT Group | 3.0% |
Legal & General Group | 2.7% |
British American Tobacco | 2.6% |
Key | % Net Assets |
---|---|
Vodafone Group | 7.6% |
BP | 7.5% |
GlaxoSmithKline | 7.2% |
Royal Dutch Shell | 6.6% |
Other | 71.1% |
Date | 08-Feb-2013 |
---|---|
NAV | 445.25p |
Currency | GBP |
Change | -0.38p |
% | -0.09% |
YTD change | 445.25p |
YTD % | n/a |
Fund Inception | 01/11/1984 |
---|---|
Fund Manager | Tim Ress |
TER | 1.33 (30-Apr-2012) |
Minimum Investment | |
---|---|
Initial | £500000 |
Additional | n/a |
Savings | £100 |
Charges | |
---|---|
Initial | n/a |
Annual Mang't | 0.65% |
Exit | n/a |
Name | % |
---|---|
Standard deviation | 0.01 |
Sharpe ratio | 0.07 |
You are here: research